Literature DB >> 16673409

Defining a minimal clinically relevant difference for the unified Parkinson's rating scale: an important but still unmet need.

Olivier Rascol.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16673409     DOI： 10.1002/mds.20913

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  4 in total

1.  Minimal Clinically Important Difference for UPDRS-III in Daily Practice.

Authors:  Álvaro Sánchez-Ferro; Michele Matarazzo; Pablo Martínez-Martín; Jose Carlos Martínez-Ávila; Agustín Gómez de la Cámara; Luca Giancardo; Teresa Arroyo Gallego; Paloma Montero; Verónica Puertas-Martín; Ignacio Obeso; Ian Butterworth; Carlos S Mendoza; Maria José Catalán; José Antonio Molina; Félix Bermejo-Pareja; Juan Carlos Martínez-Castrillo; Lydia López-Manzanares; Araceli Alonso-Cánovas; Jaime Herreros Rodríguez; Martha Gray
Journal:  Mov Disord Clin Pract       Date:  2018-06-26

2.  Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  William G Ondo; Frank Grieger; Kimberly Moran; Ralf Kohnen; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

3.  Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release.

Authors:  Robert A Hauser; Mark Forrest Gordon; Yoshikuni Mizuno; Werner Poewe; Paolo Barone; Anthony H Schapira; Olivier Rascol; Catherine Debieuvre; Mandy Fräßdorf
Journal:  Parkinsons Dis       Date:  2014-04-01

4.  Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease.

Authors:  Robert A Hauser; Aaron Ellenbogen; Sarita Khanna; Suneel Gupta; Nishit B Modi
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-22       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.